Toshiyuki Konosu

This inventor holds 15 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Sankyo Company, Limited, Daiichi Sankyo Company, Limited. Active years: 1992-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiyuki Konosu. Retrieved from https://idiyas.com/inventor/toshiyuki-konosu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 60.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 25(Granted Patents)

Location History:

Kawasaki, JP (1999 - 2003)
Tokyo, JP (1992 - 2010)
Kanagawa, JP (2013 - 2015)
Kawaski, JP (2019)

Company Filing History:

12 out of 613

Sankyo Company, Limited

patents

3 out of 462

Daiichi Sankyo Company, Limited

patents

Years Active: 1992-2019

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10399968 - Hydroxyalkyl thiadiazole derivatives (2019-09-03),

2. 8927588 - Imidazole carbonyl compound (2015-01-06),

3. 8536197 - Imidazole carbonyl compound (2013-09-17),

4. 7829580 - Cyclic amine derivative having heteroaryl ring (2010-11-09),

5. 7230023 - Water-soluble triazole fungicide (2007-06-12),

6. 6653330 - Amide-type triazole compounds (2003-11-25),

7. 6392082 - Triazole derivatives having antifungal activity (2002-05-21),

8. 6391903 - Triazole derivatives having antifungal activity (2002-05-21),

9. 6337403 - Triazole derivatives having antifungal activity (2002-01-08),

10. 6306880 - Triazole antifungal agent (2001-10-23),

11. 6300357 - Triazole antifungal agent (2001-10-09),

12. 5977152 - Triazole antifungal agent (1999-11-02),

13. 5489606 - Anti-fungal triazole derivatives, their uses (1996-02-06),

14. 5393769 - Anti-fungal triazole derivatives (1995-02-28),

15. 5134152 - Oxetane derivatives and their use as anti-fungal or fungicidal agents (1992-07-28),

Title: Innovations of Toshiyuki Konosu

Introduction

Toshiyuki Konosu is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotics. With a total of 15 patents to his name, Konosu's work addresses critical challenges in combating bacterial infections.

Latest Patents

One of Konosu's latest patents focuses on Hydroxyalkyl thiadiazole derivatives. The problem he aims to solve is the need for a new antibiotic that exhibits strong antibacterial activity against both sensitive and resistant bacteria. This antibiotic also possesses excellent solubility and a safety profile suitable for human use. Through intensive research, Konosu and his team discovered a compound represented by a specific general formula that meets these criteria. Another significant patent involves an Imidazole carbonyl compound, which aims to develop an antibiotic with a novel mechanism of action. This compound is characterized by weak cytotoxicity, high solubility in water, and the ability to inhibit both DNA gyrase GyrB and topoisomerase IV ParE subunits, demonstrating sufficient antibacterial activity.

Career Highlights

Throughout his career, Toshiyuki Konosu has worked with notable companies such as Sankyo Company, Limited and Daiichi Sankyo Company, Limited. His innovative research has led to advancements in antibiotic development, making a substantial impact on public health.

Collaborations

Konosu has collaborated with esteemed colleagues, including Sadao Oida and Takuya Uchida. Their combined expertise has contributed to the successful development of new pharmaceutical compounds.

Conclusion

Toshiyuki Konosu's work in antibiotic innovation highlights the importance of addressing bacterial resistance and improving treatment options. His contributions continue to shape the future of pharmaceutical research and development.

Profile summary based on public USPTO records.